SHODETTA BUN-MANSARAY: Open Payments
NPI 1942685847 · LOGANVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,162 in 66 payments from 11 companies in 2025. Trend: 2023 $1,608 · 2024 $1,657 · 2025 $1,162
Food & beverage: $1,162
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 12 | $201 |
| Teva Pharmaceuticals USA, Inc. | 16 | $188 |
| Alkermes, Inc. | 9 | $168 |
| Janssen Pharmaceuticals, Inc | 5 | $150 |
| Axsome Therapeutics, Inc. | 6 | $98 |
| Lundbeck LLC | 5 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $86 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| ABBVIE INC. | 3 | $57 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
Products named: INGREZZA, INVEGA SUSTENNA, UZEDY, ARISTADA, Auvelity, ABILIFY ASIMTUFII, CAPLYTA, AUSTEDO XR.
Industry payments across GA — which companies pay providers there.
